Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Depreciation & Amortization (CF): 2019-2021

Historic Depreciation & Amortization (CF) for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $123,000.

  • Black Diamond Therapeutics' Depreciation & Amortization (CF) rose 720.00% to $123,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $205,000, marking a year-over-year increase of 294.23%. This contributed to the annual value of $343,000 for FY2024, which is 21.51% down from last year.
  • As of Q4 2021, Black Diamond Therapeutics' Depreciation & Amortization (CF) stood at $123,000, which was up 186.05% from $43,000 recorded in Q3 2021.
  • Black Diamond Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $123,000 during Q4 2021, with a 5-year trough of $9,000 in Q4 2019.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $13,500 (2019), whereas its average is $25,333.
  • In the last 5 years, Black Diamond Therapeutics' Depreciation & Amortization (CF) decreased by 16.67% in 2020 and then skyrocketed by 720.00% in 2021.
  • Over the past 3 years, Black Diamond Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $9,000 in 2019, then soared by 66.67% to $15,000 in 2020, then soared by 720.00% to $123,000 in 2021.
  • Its Depreciation & Amortization (CF) was $123,000 in Q4 2021, compared to $43,000 in Q3 2021 and $20,000 in Q2 2021.